Dmitry Balyasny’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-69,686
Closed -$1.28M 2977
2026
Q1
$1.28M Sell
69,686
-21,649
-24% -$412K ﹤0.01% 1974
2025
Q4
$1.44M Sell
91,335
-12,377
-12% -$221K ﹤0.01% 2018
2025
Q3
$2.01M Sell
103,712
-19,253
-16% -$376K ﹤0.01% 1787
2025
Q2
$2.54M Buy
+122,965
New +$2.56M ﹤0.01% 1613
2025
Q1
Sell
-26,734
Closed -$639K 2761
2024
Q4
$639K Sell
26,734
-306,434
-92% -$9.73M ﹤0.01% 2106
2024
Q3
$14.1M Buy
+333,168
New +$17.5M 0.02% 785
2024
Q2
Sell
-102,349
Closed -$6.4M 2534
2024
Q1
$6.4M Sell
102,349
-68
-0.1% -$4.63K 0.01% 1122
2023
Q4
$7.67M Sell
102,417
-21,932
-18% -$1.57M 0.01% 958
2023
Q3
$10.6M Sell
124,349
-68,647
-36% -$6.51M 0.02% 830
2023
Q2
$21.1M Buy
+192,996
New +$18.3M 0.05% 509
2022
Q4
Sell
-8,316
Closed -$881K 2745
2022
Q3
$881K Buy
+8,316
New +$912K ﹤0.01% 1856
2022
Q2
Sell
-84,449
Closed -$8.81M 2721
2022
Q1
$8.81M Sell
84,449
-99,726
-54% -$10.4M 0.03% 739
2021
Q4
$22.5M Sell
184,175
-13,405
-7% -$1.49M 0.08% 363
2021
Q3
$22.7M Buy
197,580
+164,524
+498% +$17.4M 0.09% 303
2021
Q2
$3.21M Buy
+33,056
New +$2.87M 0.02% 860
2021
Q1
Sell
-3,142
Closed -$214K 1723
2020
Q4
$214K Sell
3,142
-157,967
-98% -$10.3M ﹤0.01% 1223
2020
Q3
$9.42M Buy
161,109
+107,673
+201% +$5.67M 0.07% 401
2020
Q2
$2.42M Sell
53,436
-50,414
-49% -$2.41M 0.02% 683
2020
Q1
$6M Buy
103,850
+65,032
+168% +$4.45M 0.07% 360
2019
Q4
$2.42M Sell
38,818
-48,002
-55% -$2.84M 0.01% 721
2019
Q3
$5M Buy
86,820
+77,563
+838% +$4.29M 0.03% 549
2019
Q2
$502K Buy
+9,257
New +$470K ﹤0.01% 1226
2018
Q3
Sell
-9,827
Closed -$576K 1637
2018
Q2
$576K Buy
+9,827
New +$587K ﹤0.01% 1307
2018
Q1
Sell
-116,283
Closed -$5.73M 1906
2017
Q4
$5.73M Buy
+116,283
New +$5.3M 0.02% 813
2017
Q3
Sell
-12,500
Closed -$478K 1858
2017
Q2
$488K Buy
+12,500
New +$479K ﹤0.01% 1235

Other funds holding AMN

Dmitry Balyasny's AMN Position: Q2 2026 in Review

Dmitry Balyasny sold out of AMN Healthcare (AMN) in Q2 2026, closing a stake of 69,686 shares — an estimated $1.28M sold.

Dmitry Balyasny first reported a position in AMN in Q2 2017 and held it in 25 quarters. The position peaked at $22.7M in Q3 2021. 283 funds tracked by Wall St. Rank hold AMN as of Q2 2026.

  • Dmitry Balyasny reported no remaining AMN Healthcare position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 69,686 AMN Healthcare shares in Q2 2026, an estimated $1.28M.
  • Dmitry Balyasny first reported a position in AMN Healthcare in Q2 2017 and held it in 25 quarters.
  • Dmitry Balyasny's AMN Healthcare position peaked at $22.7M in Q3 2021.
  • 283 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.